Life-threatening hemolytic-uremic syndrome treated with rituximab in an allogeneic bone marrow transplant recipient.
Ostronoff
M
M
Ostronoff
F
F
Calixto
R
R
Florêncio
R
R
Florêncio
M
M
Domingues
M C
MC
Souto Maior
A P
AP
Sucupira
A
A
Tagliari
C
C
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D006463:Hemolytic-Uremic Syndrome / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy; D000069283:Rituximab; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab